Flatiron Health has announced the development of a cloud-based electronic health record and an analytics tool to support reporting requirements for those clinics that will be selected to participate in the Oncology Care Model.
It’s been more than a year since CMS introduced the Oncology Care Model (OCM), the first specialty-specific alternative payment model introduced for physician practices that administer chemotherapy. Flatiron Health, a provider of technology platforms to the oncology community, has announced the development of a cloud-based electronic health record (OncoEMR) and an analytics tool (OncoAnalytics), to support reporting requirements for those clinics that will be selected to participate in the OCM.
Bobby Green, MD, senior vice president, Clinical Oncology, Flatiron Health, said in a statement, “Given the evolving reimbursement landscape, we planned for several OncologyCloud software platform enhancements that will allow cancer centers to easily participate in value-based care programs like OCM as soon as the programs begin.”
According to the company’s press release, both OncoEMR and OncoAnalytics have been updated to suit the needs of the OCM reporting. These upgrades to the tools include,
OCM incentivizes participating clinics to provide quality care at lower costs through an episode-based payment model, with incentives for integrated and coordinated care. The model encourages physicians to practice shared decision-making with the enrolled beneficiaries, and base treatment decisions on the best available evidence.
CMS wanted broader adoption of the model by other payers as well to allow value-based care transformation at the practice level. OCM payments will utilize a 2-part payment system for participating practices: a monthly per-beneficiary-per-month payment ($160) for the entire duration of the episode, and a performance-based payment for episodes of chemotherapy care.
According to CMS, applicants for OCM will be notified of their selection status any time now, in Spring 2016.
Pegcetacoplan for PNH More Cost-Effective Than Anti-C5 Monoclonal Antibodies
April 18th 2024A cost-utility analysis conducted from the perspective of the Italian health system found that pegcetacoplan was more effective and less costly than 2 complement 5 (C5) inhibitors for the treatment of paroxysmal nocturnal hemoglobinuria (PNH).
Read More
Navigating Health Policy in an Election Year: Insights From Dr Dennis Scanlon
April 2nd 2024On this episode of Managed Care Cast, we're talking with Dennis Scanlon, PhD, the editor in chief of The American Journal of Accountable Care®, about prior authorization, price transparency, the impact of health policy on the upcoming election, and more.
Listen
Prices for care at hospital trauma centers vary across hospitals; drug shortages reached a record high during the first quarter of 2024; although 3 of the biggest makers of asthma inhalers pledged to cap out-of-pocket costs for some US patients at $35, these do not apply to daily inhalers used by the youngest kids with asthma.
Read More
Exploring Medicare Advantage Prior Authorization Variations
March 26th 2024On this episode of Managed Care Cast, we're talking with the authors of a study published in the March 2024 issue of The American Journal of Managed Care® about their findings on variations in prior authorization use across Medicare Advantage plans.
Listen
Beyond Insulin: The Impact of Next-Generation Diabetes Technology
April 17th 2024Experts explain how new diabetes technologies like continuous glucose monitors are transforming care beyond intensive insulin therapy, offering personalized insights and improving outcomes for patients of all treatment levels.
Read More
The Biden administration recently launched the Global Health Security Strategy, a new effort to combat the spread of infectious diseases; lawmakers zeroed in on the risks of massive consolidation in health care during the first congressional hearing on the Change Healthcare hack; the FDA recently announced the recall of a pair of heart devices linked to numerous deaths and injuries.
Read More